There is a tremendous ignorance about real world realities of LMIC

Amongst HIC partners. I was interested (amused?) To see a survey yesterday in C4K asking how often we used MIBG scans to assess neuroblastoma response. The MIBG conjugated radioisotope for imaging is virtually unavailable in India so everyone uses PET-CT scanning. Our colleagues in Armenia send their patients to Russia if they really yearn for an MIBG scan. And I think the same story plays out across many LMIC and there are countries where even PET-CT scan is an unaffordable luxury. Part of me is glad we are trying to understand these real world issues, but why has it taken till 2021 to do so?

Comments

Popular posts from this blog

All are welcome!

And what we can do...

Greetings everyone!